AbbVie Inc. (ABBV) — Company Valuation Lab

Period

History

Units

At a glance

FY2025

Missing values remain blank—not zero.

Revenue

Canonical revenue for the selected period.

reported · RevenueFromContractWithCustomerExcludingAssessedTax

$61.16B

8.6% vs prior

Revenue growth

Change from the comparable prior fiscal period.

derived · year_over_year_growth

8.6%

+4.9 pts vs prior

Gross profit

Revenue less reported cost of revenue when available.

—

Unavailable

Operating income

Income from operations before non-operating items.

reported · OperatingIncomeLoss

$15.08B

65.0% vs prior

Net income

Net income attributable under the selected SEC concept.

reported · NetIncomeLoss

$4.23B

(1.2%) vs prior

Operating cash flow

Cash provided by or used in operating activities.

reported · NetCashProvidedByUsedInOperatingActivities

$19.03B

1.2% vs prior

Free cash flow

Operating cash flow less normalized positive CapEx outflow.

derived · operating_cash_flow_minus_capex

$17.82B

(0.1%) vs prior

Cash

Cash and cash equivalents at the period end.

reported · CashAndCashEquivalentsAtCarryingValue

$5.23B

(5.3%) vs prior

Total debt

Current and noncurrent debt, only when both components exist.

—

Unavailable

Equity

Reported stockholders’ equity at period end.

reported · StockholdersEquity

($3.27B)

(198.3%) vs prior

Diluted shares

Reported weighted-average diluted shares for the period.

reported · WeightedAverageNumberOfDilutedSharesOutstanding

1.77B

0.0% vs prior

Gross margin

Gross profit divided by positive revenue.

—

Unavailable

Show additional ratios and quality metrics

Operating margin

Operating income divided by positive revenue.

derived · divide

24.6%

+8.4 pts vs prior

Net margin

Net income divided by positive revenue.

derived · divide

6.9%

-0.7 pts vs prior

FCF margin

Free cash flow divided by positive revenue.

derived · divide

29.1%

-2.5 pts vs prior

3Y revenue CAGR

Compound annual revenue growth over three fiscal years.

derived · three_year_compound_annual_growth

1.8%

+1.7 pts vs prior

Current ratio

Current assets divided by positive current liabilities.

derived · divide

0.67×

1.7% vs prior

Debt / equity

Total debt divided by positive stockholders’ equity.

—

Unavailable

ROIC proxy

NOPAT proxy divided by debt plus equity less cash.

—

Unavailable

FCF consistency

Share of recent observed periods with positive FCF.

derived · positive_periods_divided_by_observed_periods

100.0%

+0.0 pts vs prior

Revenue and profit trend

Revenue, operating income, and net income on a common scale.

Revenue Operating income Net income

Margin trend

Profitability and cash conversion as a share of revenue.

Gross Operating Net FCF

Cash flow trend

CapEx is shown as a positive investment outflow; FCF equals CFO less CapEx.

Operating cash flow CapEx Free cash flow

Balance sheet trend

Period-end cash, total debt, and stockholders’ equity.

Cash Debt Equity